Ginkgo Bioworks -CW27DNABWPreferred / convertible
13F holders, Q1 2025 (March 31)3holders
1new positions
1sold out
$0.01avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Ginkgo Bioworks -CW27 (DNABW) in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Harbor Investment Advisory, LLC ($1), NewSquare Capital LLC ($1) and Vermillion & White Wealth Management Group, LLC ($0).
- Company
- Ginkgo Bioworks -CW27
- CUSIP
- 37611X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $4K |
All 13F filers, Q4 2024 → Q1 2025: 40 shares bought and 576,345 shares sold, net −576,305 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Harbor Investment Advisory, LLC | — | No change | 140 | $1 |
| NewSquare Capital LLC | — | No change | 60 | $1 |
| Vermillion & White Wealth Management Group, LLC | — | New | 40 | $0 |
"% of holder's portfolio" is DNABW's weight in each manager's 13F, not the share of Ginkgo Bioworks -CW27 the manager owns.